Tag: dna manufacturing market trends

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Deoxyribonucleic Acid (DNA) Manufacturing Market Size And Revenue Outlook Through 2030

The deoxyribonucleic acid (dna) manufacturing market size has expanded rapidly in recent years. This market is projected to increase from $5.58 billion in 2025 to $6.51 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.7%. Historically, this growth can be attributed to elements such as limited access to high-quality plasmid and synthetic dna, a reliance on traditional chemical dna synthesis methods, increasing research and development in cell and gene therapies, rising academic and industrial research initiatives, and a growing demand for oligonucleotide-based drugs.

The deoxyribonucleic acid (dna) manufacturing market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $11.95 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 16.4%. This anticipated growth during the forecast timeframe stems from progress in enzymatic and chemical DNA synthesis techniques, the enlargement of gene therapy and vaccine development initiatives, a greater embrace of GMP-grade DNA manufacturing, growing requirements for lengthy and intricate DNA structures, and the incorporation of automated DNA production systems alongside digital processes. Key trends identified for the forecast period encompass an escalating need for GMP-grade DNA in therapeutic uses, an increase in plasmid and synthetic DNA output for vaccines, a heightened uptake of gene synthesis and codon optimization services, the broadening of oligonucleotide synthesis for PCR, siRNA, and antisense purposes, and the embedded role of DNA manufacturing within cell and gene therapy development pathways.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=90418390&type=smp&name=Deoxyribonucleic%20Acid%20%28DNA%29%20Manufacturing%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Deoxyribonucleic Acid (DNA) Manufacturing Market Expansion Drivers: What’s Shaping Future Growth?

The deoxyribonucleic acid (DNA) manufacturing market is anticipated to expand, driven by the growing need for gene therapies. Gene therapies involve methods for modifying or replacing defective genes to address or avert diseases, while personalized medicine centers on customizing medical treatment according to an individual’s genetic, biological, and lifestyle profile. This heightened demand for gene therapies stems from the increasing occurrence of genetic conditions like cystic fibrosis, sickle cell anemia, and specific forms of inherited blindness. Deoxyribonucleic acid (DNA) manufacturing is crucial for gene therapies, supplying the precise, high-quality custom DNA sequences required to create and administer therapeutic genes capable of correcting or replacing flawed genetic material in individuals. An illustrative example comes from January 2024, where data from the US-based American Society of Gene & Cell Therapy revealed that in the fourth quarter of 2024, pre-registration gene therapy programs saw their most significant surge in over a year, with an 83% rise compared to the third quarter of 2024. Consequently, the growing requirement for gene therapies is propelling the expansion of the deoxyribonucleic acid (DNA) manufacturing market.

Deoxyribonucleic Acid (DNA) Manufacturing Market Segment Outlook: Which Categories Are Growing Fastest?

The deoxyribonucleic acid (dna) manufacturing market covered in this report is segmented –

1) By Type: Plasmid Deoxyribonucleic Acid (DNA), Synthetic Deoxyribonucleic Acid (DNA), Gene Synthesis, Oligonucleotide Synthesis

2) By Grade: Good Manufacturing Practices (GMP) Grade, Research And Development Grade

3) By Application: Cell And Gene Therapy, Vaccines, Oligonucleotide-Based Drugs, Other Applications

4) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations

Subsegments:

1) By Plasmid Deoxyribonucleic Acid (DNA): GMP-Grade Plasmid DNA, Non-GMP-Grade Plasmid DNA, High Copy Number Plasmids, Low Copy Number Plasmids, Bacterial Fermentation-Based Plasmid Production, Transfection-Grade Plasmid DNA

2) By Synthetic Deoxyribonucleic Acid (DNA): Enzymatic DNA Synthesis, Chemical DNA Synthesis, Long DNA Fragments, Short DNA Fragments, Single-Stranded Synthetic DNA, Double-Stranded Synthetic DNA

3) By Gene Synthesis: Custom Gene Synthesis, Standard Gene Synthesis, Complex Gene Constructs, Codon Optimization Services, Gene Library Synthesis

4) By Oligonucleotide Synthesis: DNA Oligonucleotides, Modified Oligonucleotides, Long Oligonucleotides, PCR Primers, SiRNA And Antisense Oligos, Adapter And Linker Oligos

Deoxyribonucleic Acid (DNA) Manufacturing Market Strategic Trends: What Defines The Next Growth Phase?

Major companies in the DNA manufacturing market are prioritizing the development of cutting-edge methods, such as GMP-grade plasmid DNA production, to improve the quality, safety, and scalability of gene and cell therapy applications. GMP-grade plasmid DNA production denotes the creation of plasmid DNA under Good Manufacturing Practice (GMP) conditions, which are regulatory guidelines established to ensure the quality, safety, and consistency of biopharmaceutical products. As an illustration, in April 2025, ProBio Genomics Inc., a US-based contract development and manufacturing organization (CDMO), commenced its GMP Plasmid DNA Manufacturing Services in Hopewell, featuring in-house analytical testing, method development, and project management. This service provides distinct advantages, including integrated process development, analytical testing, method development, and project management, thereby removing the necessity for multiple suppliers and shortening development timelines. The offering guarantees high-quality results with a supercoiled plasmid DNA content of =85% while also minimizing potential contamination risks. Furthermore, ProBio makes available GMP-like plasmids with a four-week delivery period and full GMP-grade plasmids within three months.

Deoxyribonucleic Acid (DNA) Manufacturing Market Leading Companies And Competitive Benchmarking

Major companies operating in the deoxyribonucleic acid (dna) manufacturing market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Kaneka Corporation, Catalent Inc., Charles River Laboratories International Inc., WuXi Biologics Inc., AGC Biologics Inc., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio USA Inc., Twist Bioscience Corp., Ajinomoto Bio-Pharma Services, OriGene Technologies Inc., DNA Script SAS, Eurofins Genomics LLC, Touchlight Genetics Ltd., Elegen Inc., VGXI Inc., PlasmidFactory GmbH & Co. KG.

View The Full Deoxyribonucleic Acid (DNA) Manufacturing Market Report:

https://thebusinessresearchcompany.com/report/deoxyribonucleic-acid-dna-manufacturing-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Deoxyribonucleic Acid (DNA) Manufacturing Market Regional Analysis And Top Geography

North America was the largest region in the deoxyribonucleic acid (DNA) manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deoxyribonucleic acid (dna) manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Deoxyribonucleic Acid (DNA) Manufacturing Market Size Outlook: How Fast Will Revenue Grow Through 2030?

In recent years, the market for deoxyribonucleic acid (DNA) manufacturing has experienced rapid expansion. Its value is projected to rise from $5.58 billion in 2025 to $6.51 billion in 2026, reflecting a compound annual growth rate (CAGR) of 16.7%. Several factors contributed to this historical growth, including restricted availability of high-quality plasmid and synthetic DNA, dependence on conventional chemical DNA synthesis techniques, increased research and development in cell and gene therapies, a surge in academic and industrial research efforts, and a growing need for oligonucleotide-based medications.

The market for deoxyribonucleic acid (DNA) manufacturing is expected to experience rapid expansion during the next several years. By 2030, it is projected to reach $11.95 billion, driven by a compound annual growth rate (CAGR) of 16.4%. Key drivers for this growth in the forecast period include progress in enzymatic and chemical DNA synthesis techniques, the growth of gene therapy and vaccine development programs, broader implementation of GMP-grade DNA production, an increased need for lengthy and intricate DNA constructs, and the incorporation of automated DNA manufacturing systems along with digital workflows. Significant trends shaping the forecast period consist of a heightened need for GMP-grade DNA for therapeutic uses, expanded output of plasmid and synthetic DNA for vaccines, wider use of gene synthesis and codon optimization services, greater reliance on oligonucleotide synthesis for applications such as PCR, siRNA, and antisense technologies, and the integration of DNA manufacturing into cell and gene therapy initiatives.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27272&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Deoxyribonucleic Acid (DNA) Manufacturing Market Expansion Supported By Key Demand Factors

The growing need for gene therapies is anticipated to accelerate the expansion of the deoxyribonucleic acid (DNA) manufacturing market in the coming period. Gene therapies involve methods designed to alter or replace defective genes to address or prevent illnesses, whereas personalized medicine customizes medical treatments based on an individual’s genetic, biological, and lifestyle factors. This rising demand for gene therapies is fueled by the increasing occurrence of genetic conditions like cystic fibrosis, sickle cell disease, and some forms of hereditary blindness. DNA manufacturing facilitates gene therapies by supplying the high-grade, tailored DNA sequences required to create and deliver therapeutic genes capable of fixing or substituting faulty genetic material within patients. A case in point is January 2024, when the American Society of Gene & Cell Therapy, a US-based entity, reported that the number of pre-registration gene therapy initiatives had grown by 83% in the fourth quarter of 2024 compared to the third quarter of the same year, marking the most significant increase in over twelve months. Consequently, the escalating demand for gene therapies is propelling the growth of the deoxyribonucleic acid (DNA) manufacturing market.

Deoxyribonucleic Acid (DNA) Manufacturing Market Segmentation And Category Breakdown

The deoxyribonucleic acid (dna) manufacturing market covered in this report is segmented –

1) By Type: Plasmid Deoxyribonucleic Acid (DNA), Synthetic Deoxyribonucleic Acid (DNA), Gene Synthesis, Oligonucleotide Synthesis

2) By Grade: Good Manufacturing Practices (GMP) Grade, Research And Development Grade

3) By Application: Cell And Gene Therapy, Vaccines, Oligonucleotide-Based Drugs, Other Applications

4) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations

Subsegments:

1) By Plasmid Deoxyribonucleic Acid (DNA): GMP-Grade Plasmid DNA, Non-GMP-Grade Plasmid DNA, High Copy Number Plasmids, Low Copy Number Plasmids, Bacterial Fermentation-Based Plasmid Production, Transfection-Grade Plasmid DNA

2) By Synthetic Deoxyribonucleic Acid (DNA): Enzymatic DNA Synthesis, Chemical DNA Synthesis, Long DNA Fragments, Short DNA Fragments, Single-Stranded Synthetic DNA, Double-Stranded Synthetic DNA

3) By Gene Synthesis: Custom Gene Synthesis, Standard Gene Synthesis, Complex Gene Constructs, Codon Optimization Services, Gene Library Synthesis

4) By Oligonucleotide Synthesis: DNA Oligonucleotides, Modified Oligonucleotides, Long Oligonucleotides, PCR Primers, SiRNA And Antisense Oligos, Adapter And Linker Oligos

Deoxyribonucleic Acid (DNA) Manufacturing Market Growth Trends Influencing Competitive Dynamics

Key players in the DNA manufacturing industry are prioritizing the development of advanced strategies, particularly GMP-grade plasmid DNA production, to improve the quality, safety, and scalability of gene and cell therapy solutions. This type of production involves creating plasmid DNA under Good Manufacturing Practice (GMP) standards, which are regulatory requirements designed to guarantee the quality, safety, and uniformity of biopharmaceutical products. As an example, in April 2025, ProBio Genomics Inc., a US-based contract development and manufacturing organization (CDMO), introduced GMP Plasmid DNA Manufacturing Services in Hopewell, featuring in-house analytical testing, method development, and project management. These services provide distinct advantages, such as integrated process development, analytical testing, method development, and project management, which remove the need for multiple vendors and accelerate development timelines. The offering ensures superior output with at least 85% supercoiled plasmid DNA content and reduces contamination risks. Additionally, ProBio supplies GMP-like plasmids within four weeks and full GMP-grade plasmids in three months.

Deoxyribonucleic Acid (DNA) Manufacturing Market Competitive Analysis Of Major Industry Participants

Major companies operating in the deoxyribonucleic acid (dna) manufacturing market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Kaneka Corporation, Catalent Inc., Charles River Laboratories International Inc., WuXi Biologics Inc., AGC Biologics Inc., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio USA Inc., Twist Bioscience Corp., Ajinomoto Bio-Pharma Services, OriGene Technologies Inc., DNA Script SAS, Eurofins Genomics LLC, Touchlight Genetics Ltd., Elegen Inc., VGXI Inc., PlasmidFactory GmbH & Co. KG.

Access The Complete Deoxyribonucleic Acid (DNA) Manufacturing Market Report:

https://www.thebusinessresearchcompany.com/report/deoxyribonucleic-acid-dna-manufacturing-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Deoxyribonucleic Acid (DNA) Manufacturing Market Regional Distribution: Which Areas Drive Market Expansion?

North America was the largest region in the deoxyribonucleic acid (DNA) manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deoxyribonucleic acid (dna) manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Estimated Growth In Market Size Of The Deoxyribonucleic Acid (DNA) Manufacturing Market During 2026–2030?

The deoxyribonucleic acid (dna) manufacturing market has seen significant expansion in recent years. This market is expected to increase from $5.58 billion in 2025 to $6.51 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 16.7%. The historical growth of the market can be linked to factors such as limited access to high-quality plasmid and synthetic dna, dependence on traditional chemical dna synthesis methods, increased research and development in cell and gene therapies, a rise in academic and industrial research projects, and growing demand for oligonucleotide-based drugs.

The market size for deoxyribonucleic acid (DNA) manufacturing is anticipated to experience substantial growth in the coming years. It is projected to expand to $11.95 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 16.4%. This expected growth during the forecast period is attributable to advancements in enzymatic and chemical DNA synthesis technologies, the expansion of gene therapy and vaccine pipelines, a rise in the adoption of GMP-grade DNA production, an increasing demand for long and complex DNA constructs, and the integration of automated DNA manufacturing platforms with digital workflows. Furthermore, significant trends for this period include a growing need for GMP-grade DNA in therapeutic applications, an increase in plasmid and synthetic DNA production for vaccines, a wider embrace of gene synthesis and codon optimization services, the expansion of oligonucleotide synthesis for PCR, siRNA, and antisense applications, and the embedding of DNA manufacturing processes within cell and gene therapy pipelines.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27272&type=smp

Which Drivers Are Advancing The Deoxyribonucleic Acid (DNA) Manufacturing Market Growth?

The projected expansion of the deoxyribonucleic acid (DNA) manufacturing market is expected to be fueled by the growing need for gene therapies. Gene therapies encompass methods to alter or substitute defective genes for disease treatment or prevention. The escalating requirement for these therapies is primarily due to the increasing occurrence of genetic conditions like cystic fibrosis, sickle cell anemia, and certain forms of inherited blindness. Deoxyribonucleic acid (DNA) manufacturing plays a crucial role in gene therapies by supplying the essential high-quality, customized DNA sequences required for developing and delivering therapeutic genes that can rectify or substitute flawed genetic material in patients. For example, in January 2024, the American Society of Gene & Cell Therapy, a US-based organization, noted a significant increase of 83% in pre-registration gene therapy programs in the fourth quarter of 2024 compared to the third quarter of 2024, representing the largest rise in over a year. Consequently, the rising demand for gene therapies is propelling the growth of the deoxyribonucleic acid (DNA) manufacturing market.

What Segment Categories Are Evaluated In The Deoxyribonucleic Acid (DNA) Manufacturing Market Study?

The deoxyribonucleic acid (dna) manufacturing market covered in this report is segmented –

1) By Type: Plasmid Deoxyribonucleic Acid (DNA), Synthetic Deoxyribonucleic Acid (DNA), Gene Synthesis, Oligonucleotide Synthesis

2) By Grade: Good Manufacturing Practices (GMP) Grade, Research And Development Grade

3) By Application: Cell And Gene Therapy, Vaccines, Oligonucleotide-Based Drugs, Other Applications

4) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations

Subsegments:

1) By Plasmid Deoxyribonucleic Acid (DNA): GMP-Grade Plasmid DNA, Non-GMP-Grade Plasmid DNA, High Copy Number Plasmids, Low Copy Number Plasmids, Bacterial Fermentation-Based Plasmid Production, Transfection-Grade Plasmid DNA

2) By Synthetic Deoxyribonucleic Acid (DNA): Enzymatic DNA Synthesis, Chemical DNA Synthesis, Long DNA Fragments, Short DNA Fragments, Single-Stranded Synthetic DNA, Double-Stranded Synthetic DNA

3) By Gene Synthesis: Custom Gene Synthesis, Standard Gene Synthesis, Complex Gene Constructs, Codon Optimization Services, Gene Library Synthesis

4) By Oligonucleotide Synthesis: DNA Oligonucleotides, Modified Oligonucleotides, Long Oligonucleotides, PCR Primers, SiRNA And Antisense Oligos, Adapter And Linker Oligos

What Trends Are Driving Changes In The Deoxyribonucleic Acid (DNA) Manufacturing Market?

Leading companies in the DNA manufacturing market are actively developing innovative strategies, such as the production of GMP-grade plasmid DNA, to enhance the quality, safety, and scalability of applications in gene and cell therapy. GMP-grade plasmid DNA production signifies the creation of plasmid DNA under Good Manufacturing Practice (GMP) guidelines, which are regulatory standards that guarantee the quality, safety, and consistency of biopharmaceutical products. For example, in April 2025, ProBio Genomics Inc., a US-based contract development and manufacturing organization (CDMO), inaugurated GMP Plasmid DNA Manufacturing Services in Hopewell, providing integrated analytical testing, method development, and project management. This service boasts unique attributes including internal process development, analytical testing, method creation, and project supervision, thus removing the need for multiple vendors and accelerating development schedules. The service assures a high-quality outcome with =85% supercoiled plasmid DNA content and effectively mitigates contamination risks. ProBio additionally offers GMP-like plasmids with a four-week delivery period and full GMP-grade plasmids obtainable within three months.

Which Key Players Are Active In The Deoxyribonucleic Acid (DNA) Manufacturing Market?

Major companies operating in the deoxyribonucleic acid (dna) manufacturing market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Kaneka Corporation, Catalent Inc., Charles River Laboratories International Inc., WuXi Biologics Inc., AGC Biologics Inc., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio USA Inc., Twist Bioscience Corp., Ajinomoto Bio-Pharma Services, OriGene Technologies Inc., DNA Script SAS, Eurofins Genomics LLC, Touchlight Genetics Ltd., Elegen Inc., VGXI Inc., PlasmidFactory GmbH & Co. KG.

Access The Complete Deoxyribonucleic Acid (DNA) Manufacturing Market Report:

https://www.thebusinessresearchcompany.com/report/deoxyribonucleic-acid-dna-manufacturing-global-market-report

What Is The Largest Regional Market In The Deoxyribonucleic Acid (DNA) Manufacturing Market?

North America was the largest region in the deoxyribonucleic acid (DNA) manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deoxyribonucleic acid (dna) manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Deoxyribonucleic Acid (DNA) Manufacturing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=27272&type=smp

Browse Through More Reports Similar to the Global Deoxyribonucleic Acid (DNA) Manufacturing Market 2026, By The Business Research Company

Electronic Equipment Repair Service Market Report 2026

https://www.thebusinessresearchcompany.com/report/electronic-equipment-repair-service-global-market-report

Maintenance Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/maintenance-services-global-market-report

Industrial Maintenance Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/industrial-maintenance-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Deoxyribonucleic Acid (DNA) Manufacturing Market In 2026, And How Will Its Value Evolve By 2030?

The deoxyribonucleic acid (dna) manufacturing market size has experienced rapid growth in recent years. Its value is projected to rise from $5.58 billion in 2025 to $6.51 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.7%. The expansion observed in the historic period can be ascribed to factors such as limited access to high-quality plasmid and synthetic dna, continued reliance on traditional chemical dna synthesis methods, expanding r&d in cell and gene therapies, a surge in academic and industrial research initiatives, and the escalating demand for oligonucleotide-based drugs.

The deoxyribonucleic acid (dna) manufacturing market is projected to experience substantial growth over the coming years. This market is anticipated to reach $11.95 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 16.4%. This expansion during the forecast period is fueled by advancements in enzymatic and chemical DNA synthesis technologies, the broadening of gene therapy and vaccine development pipelines, increasing embrace of GMP-grade DNA production, growing demand for lengthy and intricate DNA constructs, and the integration of automated DNA manufacturing platforms and digital workflows. Key trends anticipated for this period encompass a surge in demand for GMP-grade DNA for therapeutic uses, an increase in plasmid and synthetic DNA production for vaccine development, greater uptake of gene synthesis and codon optimization services, the widening scope of oligonucleotide synthesis for PCR, siRNA, and antisense applications, and the embedding of DNA manufacturing into cell and gene therapy pipelines.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27272&type=smp

Which Factors Are Influencing The Growth Of The Deoxyribonucleic Acid (DNA) Manufacturing Market?

The deoxyribonucleic acid (DNA) manufacturing market is anticipated to expand in the future, fueled by the rising demand for gene therapies. Gene therapies are defined as methods used to modify or replace faulty genes for disease treatment or prevention, while personalized medicine involves customizing medical treatment based on an individual’s genetic, biological, and lifestyle attributes. This heightened need for gene therapies stems from the growing incidence of genetic conditions like cystic fibrosis, sickle cell anemia, and particular forms of inherited blindness. Deoxyribonucleic acid (DNA) manufacturing facilitates gene therapies through its provision of bespoke, premium DNA sequences essential for creating and administering therapeutic genes capable of correcting or replacing deficient genetic material in individuals. As an illustration, in January 2024, the American Society of Gene & Cell Therapy, a US-based organization, reported that the fourth quarter of 2024 saw the number of pre-registration gene therapy programs achieve its most significant increase in over a year, with an 83% rise compared to the third quarter of 2024. Consequently, the expanding demand for gene therapies is propelling the growth of the deoxyribonucleic acid (DNA) manufacturing market.

Which Segment Types Are Examined In The Deoxyribonucleic Acid (DNA) Manufacturing Market Segment Study?

The deoxyribonucleic acid (dna) manufacturing market covered in this report is segmented –

1) By Type: Plasmid Deoxyribonucleic Acid (DNA), Synthetic Deoxyribonucleic Acid (DNA), Gene Synthesis, Oligonucleotide Synthesis

2) By Grade: Good Manufacturing Practices (GMP) Grade, Research And Development Grade

3) By Application: Cell And Gene Therapy, Vaccines, Oligonucleotide-Based Drugs, Other Applications

4) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations

Subsegments:

1) By Plasmid Deoxyribonucleic Acid (DNA): GMP-Grade Plasmid DNA, Non-GMP-Grade Plasmid DNA, High Copy Number Plasmids, Low Copy Number Plasmids, Bacterial Fermentation-Based Plasmid Production, Transfection-Grade Plasmid DNA

2) By Synthetic Deoxyribonucleic Acid (DNA): Enzymatic DNA Synthesis, Chemical DNA Synthesis, Long DNA Fragments, Short DNA Fragments, Single-Stranded Synthetic DNA, Double-Stranded Synthetic DNA

3) By Gene Synthesis: Custom Gene Synthesis, Standard Gene Synthesis, Complex Gene Constructs, Codon Optimization Services, Gene Library Synthesis

4) By Oligonucleotide Synthesis: DNA Oligonucleotides, Modified Oligonucleotides, Long Oligonucleotides, PCR Primers, SiRNA And Antisense Oligos, Adapter And Linker Oligos

Which Trends Are Contributing To Changes In The Deoxyribonucleic Acid (DNA) Manufacturing Market?

Major companies in the DNA manufacturing market are concentrating on developing innovative approaches, such as GMP-grade plasmid DNA production, to improve the quality, safety, and scalability of gene and cell therapy applications. GMP-grade plasmid DNA production refers to manufacturing plasmid DNA under Good Manufacturing Practice (GMP) conditions, which are regulatory guidelines designed to ensure the quality, safety, and consistency of biopharmaceutical products. For instance, in April 2025, ProBio Genomics Inc., a US-based contract development and manufacturing organization (CDMO), launched GMP Plasmid DNA Manufacturing Services in Hopewell, featuring in-house analytical testing, method development, and project management. This offering includes unique features like in-house process development, analytical testing, method development, and project management, which eliminates the need for multiple suppliers and accelerates development timelines. The service guarantees a high-quality output with ≥85% supercoiled plasmid DNA content while minimizing contamination risks. ProBio additionally provides GMP-like plasmids with a four-week delivery timeline and full GMP-grade plasmids within three months.

Which Players Are Part Of The Competitive Landscape Of The Deoxyribonucleic Acid (DNA) Manufacturing Market?

Major companies operating in the deoxyribonucleic acid (dna) manufacturing market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Kaneka Corporation, Catalent Inc., Charles River Laboratories International Inc., WuXi Biologics Inc., AGC Biologics Inc., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio USA Inc., Twist Bioscience Corp., Ajinomoto Bio-Pharma Services, OriGene Technologies Inc., DNA Script SAS, Eurofins Genomics LLC, Touchlight Genetics Ltd., Elegen Inc., VGXI Inc., PlasmidFactory GmbH & Co. KG.

Get The Full Deoxyribonucleic Acid (DNA) Manufacturing Market Report:

https://www.thebusinessresearchcompany.com/report/deoxyribonucleic-acid-dna-manufacturing-global-market-report

Which Region Has The Greatest Market Share In The Deoxyribonucleic Acid (DNA) Manufacturing Market?

North America was the largest region in the deoxyribonucleic acid (DNA) manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deoxyribonucleic acid (dna) manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Deoxyribonucleic Acid (DNA) Manufacturing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/deoxyribonucleic-acid-dna-manufacturing-global-market-report

Browse Through More Reports Similar to the Global Deoxyribonucleic Acid (DNA) Manufacturing Market 2026, By The Business Research Company

Electronic Equipment Repair Service Market Report 2026

https://www.thebusinessresearchcompany.com/report/electronic-equipment-repair-service-global-market-report

Maintenance Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/maintenance-services-global-market-report

Industrial Maintenance Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/industrial-maintenance-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Deoxyribonucleic Acid (DNA) Manufacturing Market Evolve From 2026 To 2030?

The deoxyribonucleic acid (dna) manufacturing market has experienced substantial expansion recently. This market is projected to expand from $5.58 billion in 2025 to $6.51 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.7%. Historically, this growth has stemmed from several factors, including challenges in obtaining high-quality plasmid and synthetic dna, a dependence on conventional chemical dna synthesis techniques, escalating research and development efforts in cell and gene therapies, increasing academic and industrial research projects, and a surging need for oligonucleotide-based medications.

The deoxyribonucleic acid (dna) manufacturing market size is anticipated to experience substantial growth in the coming years. It is forecast to expand to $11.95 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 16.4%. This projected expansion during the forecast period is primarily driven by advancements in enzymatic and chemical DNA synthesis technologies, the broadening of gene therapy and vaccine pipelines, increasing uptake of GMP-grade DNA production, a rising demand for long and complex DNA constructs, and the integration of automated DNA manufacturing platforms and digital workflows. Significant trends for this period include an escalating demand for GMP-grade DNA in therapeutic applications, an increase in plasmid and synthetic DNA production for vaccines, the growing adoption of gene synthesis and codon optimization services, the expansion of oligonucleotide synthesis for PCR, siRNA, and antisense applications, and the embedding of DNA manufacturing within cell and gene therapy development pipelines.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27272&type=smp

What Drivers Are Influencing The Deoxyribonucleic Acid (DNA) Manufacturing Market?

The deoxyribonucleic acid (DNA) manufacturing market is anticipated to expand, driven by the escalating demand for gene therapies. Gene therapies involve methods for altering or substituting defective genes to prevent or treat illnesses, while personalized medicine focuses on customizing medical care based on an individual’s genetic makeup, biology, and lifestyle attributes. This growing need for gene therapies stems from the increasing occurrence of genetic conditions, including cystic fibrosis, sickle cell anemia, and specific forms of inherited blindness. Deoxyribonucleic acid (DNA) manufacturing plays a crucial role in gene therapies, supplying the specialized, high-quality DNA sequences required for creating and delivering therapeutic genes capable of rectifying or substituting defective genetic material in patients. For instance, in January 2024, according to the American Society of Gene & Cell Therapy, a US-based organization, in fourth quarter of 2024, the number of pre-registration gene therapy programs experienced its largest increase in over a year, rising 83% compared to third quarter of 2024. Consequently, the expanding demand for gene therapies is fueling the expansion of the deoxyribonucleic acid (DNA) manufacturing market.

Which Segment Areas Are Covered In The Deoxyribonucleic Acid (DNA) Manufacturing Market Analysis?

The deoxyribonucleic acid (dna) manufacturing market covered in this report is segmented –

1) By Type: Plasmid Deoxyribonucleic Acid (DNA), Synthetic Deoxyribonucleic Acid (DNA), Gene Synthesis, Oligonucleotide Synthesis

2) By Grade: Good Manufacturing Practices (GMP) Grade, Research And Development Grade

3) By Application: Cell And Gene Therapy, Vaccines, Oligonucleotide-Based Drugs, Other Applications

4) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations

Subsegments:

1) By Plasmid Deoxyribonucleic Acid (DNA): GMP-Grade Plasmid DNA, Non-GMP-Grade Plasmid DNA, High Copy Number Plasmids, Low Copy Number Plasmids, Bacterial Fermentation-Based Plasmid Production, Transfection-Grade Plasmid DNA

2) By Synthetic Deoxyribonucleic Acid (DNA): Enzymatic DNA Synthesis, Chemical DNA Synthesis, Long DNA Fragments, Short DNA Fragments, Single-Stranded Synthetic DNA, Double-Stranded Synthetic DNA

3) By Gene Synthesis: Custom Gene Synthesis, Standard Gene Synthesis, Complex Gene Constructs, Codon Optimization Services, Gene Library Synthesis

4) By Oligonucleotide Synthesis: DNA Oligonucleotides, Modified Oligonucleotides, Long Oligonucleotides, PCR Primers, SiRNA And Antisense Oligos, Adapter And Linker Oligos

What Key Developments And Trends Are Impacting The Deoxyribonucleic Acid (DNA) Manufacturing Market?

Companies prominent in the DNA manufacturing market are concentrating on creating innovative methods, such as GMP-grade plasmid DNA production, to improve the quality, safety, and scalability of gene and cell therapy applications. GMP-grade plasmid DNA production refers to the manufacturing of plasmid DNA under Good Manufacturing Practice (GMP) conditions, which are regulatory guidelines designed to assure the quality, safety, and consistency of biopharmaceutical products. For instance, in April 2025, ProBio Genomics Inc., a US-based contract development and manufacturing organization (CDMO), launched GMP Plasmid DNA Manufacturing Services in Hopewell, complete with in-house analytical testing, method development, and project management. This service offers distinct features, including in-house process development, analytical testing, method development, and project management, thereby removing the necessity for multiple suppliers and accelerating development timelines. The service guarantees a high-quality output with =85% supercoiled plasmid DNA content while diminishing contamination risks. ProBio further provides GMP-like plasmids with a four-week delivery timeline and full GMP-grade plasmids within three months.

Which Global Companies Are Actively Competing In The Deoxyribonucleic Acid (DNA) Manufacturing Market?

Major companies operating in the deoxyribonucleic acid (dna) manufacturing market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Kaneka Corporation, Catalent Inc., Charles River Laboratories International Inc., WuXi Biologics Inc., AGC Biologics Inc., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio USA Inc., Twist Bioscience Corp., Ajinomoto Bio-Pharma Services, OriGene Technologies Inc., DNA Script SAS, Eurofins Genomics LLC, Touchlight Genetics Ltd., Elegen Inc., VGXI Inc., PlasmidFactory GmbH & Co. KG.

Read the full deoxyribonucleic acid (dna) manufacturing market report here:

https://www.thebusinessresearchcompany.com/report/deoxyribonucleic-acid-dna-manufacturing-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Deoxyribonucleic Acid (DNA) Manufacturing Market?

North America was the largest region in the deoxyribonucleic acid (DNA) manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deoxyribonucleic acid (dna) manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Deoxyribonucleic Acid (DNA) Manufacturing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27272&type=smp

Browse Through More Reports Similar to the Global Deoxyribonucleic Acid (DNA) Manufacturing Market 2026, By The Business Research Company

Electronic Equipment Repair Service Market Report 2026

https://www.thebusinessresearchcompany.com/report/electronic-equipment-repair-service-global-market-report

Maintenance Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/maintenance-services-global-market-report

Industrial Maintenance Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/industrial-maintenance-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Deoxyribonucleic Acid (DNA) Manufacturing Market Evolve From 2026 To 2030?

The deoxyribonucleic acid (dna) manufacturing market has experienced substantial expansion recently. This market is projected to expand from $5.58 billion in 2025 to $6.51 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.7%. Historically, this growth has stemmed from several factors, including challenges in obtaining high-quality plasmid and synthetic dna, a dependence on conventional chemical dna synthesis techniques, escalating research and development efforts in cell and gene therapies, increasing academic and industrial research projects, and a surging need for oligonucleotide-based medications.

The deoxyribonucleic acid (dna) manufacturing market size is anticipated to experience substantial growth in the coming years. It is forecast to expand to $11.95 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 16.4%. This projected expansion during the forecast period is primarily driven by advancements in enzymatic and chemical DNA synthesis technologies, the broadening of gene therapy and vaccine pipelines, increasing uptake of GMP-grade DNA production, a rising demand for long and complex DNA constructs, and the integration of automated DNA manufacturing platforms and digital workflows. Significant trends for this period include an escalating demand for GMP-grade DNA in therapeutic applications, an increase in plasmid and synthetic DNA production for vaccines, the growing adoption of gene synthesis and codon optimization services, the expansion of oligonucleotide synthesis for PCR, siRNA, and antisense applications, and the embedding of DNA manufacturing within cell and gene therapy development pipelines.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27272&type=smp

What Drivers Are Influencing The Deoxyribonucleic Acid (DNA) Manufacturing Market?

The deoxyribonucleic acid (DNA) manufacturing market is anticipated to expand, driven by the escalating demand for gene therapies. Gene therapies involve methods for altering or substituting defective genes to prevent or treat illnesses, while personalized medicine focuses on customizing medical care based on an individual’s genetic makeup, biology, and lifestyle attributes. This growing need for gene therapies stems from the increasing occurrence of genetic conditions, including cystic fibrosis, sickle cell anemia, and specific forms of inherited blindness. Deoxyribonucleic acid (DNA) manufacturing plays a crucial role in gene therapies, supplying the specialized, high-quality DNA sequences required for creating and delivering therapeutic genes capable of rectifying or substituting defective genetic material in patients. For instance, in January 2024, according to the American Society of Gene & Cell Therapy, a US-based organization, in fourth quarter of 2024, the number of pre-registration gene therapy programs experienced its largest increase in over a year, rising 83% compared to third quarter of 2024. Consequently, the expanding demand for gene therapies is fueling the expansion of the deoxyribonucleic acid (DNA) manufacturing market.

Which Segment Areas Are Covered In The Deoxyribonucleic Acid (DNA) Manufacturing Market Analysis?

The deoxyribonucleic acid (dna) manufacturing market covered in this report is segmented –

1) By Type: Plasmid Deoxyribonucleic Acid (DNA), Synthetic Deoxyribonucleic Acid (DNA), Gene Synthesis, Oligonucleotide Synthesis

2) By Grade: Good Manufacturing Practices (GMP) Grade, Research And Development Grade

3) By Application: Cell And Gene Therapy, Vaccines, Oligonucleotide-Based Drugs, Other Applications

4) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations

Subsegments:

1) By Plasmid Deoxyribonucleic Acid (DNA): GMP-Grade Plasmid DNA, Non-GMP-Grade Plasmid DNA, High Copy Number Plasmids, Low Copy Number Plasmids, Bacterial Fermentation-Based Plasmid Production, Transfection-Grade Plasmid DNA

2) By Synthetic Deoxyribonucleic Acid (DNA): Enzymatic DNA Synthesis, Chemical DNA Synthesis, Long DNA Fragments, Short DNA Fragments, Single-Stranded Synthetic DNA, Double-Stranded Synthetic DNA

3) By Gene Synthesis: Custom Gene Synthesis, Standard Gene Synthesis, Complex Gene Constructs, Codon Optimization Services, Gene Library Synthesis

4) By Oligonucleotide Synthesis: DNA Oligonucleotides, Modified Oligonucleotides, Long Oligonucleotides, PCR Primers, SiRNA And Antisense Oligos, Adapter And Linker Oligos

What Key Developments And Trends Are Impacting The Deoxyribonucleic Acid (DNA) Manufacturing Market?

Companies prominent in the DNA manufacturing market are concentrating on creating innovative methods, such as GMP-grade plasmid DNA production, to improve the quality, safety, and scalability of gene and cell therapy applications. GMP-grade plasmid DNA production refers to the manufacturing of plasmid DNA under Good Manufacturing Practice (GMP) conditions, which are regulatory guidelines designed to assure the quality, safety, and consistency of biopharmaceutical products. For instance, in April 2025, ProBio Genomics Inc., a US-based contract development and manufacturing organization (CDMO), launched GMP Plasmid DNA Manufacturing Services in Hopewell, complete with in-house analytical testing, method development, and project management. This service offers distinct features, including in-house process development, analytical testing, method development, and project management, thereby removing the necessity for multiple suppliers and accelerating development timelines. The service guarantees a high-quality output with =85% supercoiled plasmid DNA content while diminishing contamination risks. ProBio further provides GMP-like plasmids with a four-week delivery timeline and full GMP-grade plasmids within three months.

Which Global Companies Are Actively Competing In The Deoxyribonucleic Acid (DNA) Manufacturing Market?

Major companies operating in the deoxyribonucleic acid (dna) manufacturing market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Kaneka Corporation, Catalent Inc., Charles River Laboratories International Inc., WuXi Biologics Inc., AGC Biologics Inc., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio USA Inc., Twist Bioscience Corp., Ajinomoto Bio-Pharma Services, OriGene Technologies Inc., DNA Script SAS, Eurofins Genomics LLC, Touchlight Genetics Ltd., Elegen Inc., VGXI Inc., PlasmidFactory GmbH & Co. KG.

Read the full deoxyribonucleic acid (dna) manufacturing market report here:

https://www.thebusinessresearchcompany.com/report/deoxyribonucleic-acid-dna-manufacturing-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Deoxyribonucleic Acid (DNA) Manufacturing Market?

North America was the largest region in the deoxyribonucleic acid (DNA) manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deoxyribonucleic acid (dna) manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Deoxyribonucleic Acid (DNA) Manufacturing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27272&type=smp

Browse Through More Reports Similar to the Global Deoxyribonucleic Acid (DNA) Manufacturing Market 2026, By The Business Research Company

Electronic Equipment Repair Service Market Report 2026

https://www.thebusinessresearchcompany.com/report/electronic-equipment-repair-service-global-market-report

Maintenance Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/maintenance-services-global-market-report

Industrial Maintenance Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/industrial-maintenance-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Deoxyribonucleic Acid (DNA) Manufacturing Market Evolve From 2026 To 2030?

The deoxyribonucleic acid (dna) manufacturing market has experienced substantial expansion recently. This market is projected to expand from $5.58 billion in 2025 to $6.51 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.7%. Historically, this growth has stemmed from several factors, including challenges in obtaining high-quality plasmid and synthetic dna, a dependence on conventional chemical dna synthesis techniques, escalating research and development efforts in cell and gene therapies, increasing academic and industrial research projects, and a surging need for oligonucleotide-based medications.

The deoxyribonucleic acid (dna) manufacturing market size is anticipated to experience substantial growth in the coming years. It is forecast to expand to $11.95 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 16.4%. This projected expansion during the forecast period is primarily driven by advancements in enzymatic and chemical DNA synthesis technologies, the broadening of gene therapy and vaccine pipelines, increasing uptake of GMP-grade DNA production, a rising demand for long and complex DNA constructs, and the integration of automated DNA manufacturing platforms and digital workflows. Significant trends for this period include an escalating demand for GMP-grade DNA in therapeutic applications, an increase in plasmid and synthetic DNA production for vaccines, the growing adoption of gene synthesis and codon optimization services, the expansion of oligonucleotide synthesis for PCR, siRNA, and antisense applications, and the embedding of DNA manufacturing within cell and gene therapy development pipelines.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27272&type=smp

What Drivers Are Influencing The Deoxyribonucleic Acid (DNA) Manufacturing Market?

The deoxyribonucleic acid (DNA) manufacturing market is anticipated to expand, driven by the escalating demand for gene therapies. Gene therapies involve methods for altering or substituting defective genes to prevent or treat illnesses, while personalized medicine focuses on customizing medical care based on an individual’s genetic makeup, biology, and lifestyle attributes. This growing need for gene therapies stems from the increasing occurrence of genetic conditions, including cystic fibrosis, sickle cell anemia, and specific forms of inherited blindness. Deoxyribonucleic acid (DNA) manufacturing plays a crucial role in gene therapies, supplying the specialized, high-quality DNA sequences required for creating and delivering therapeutic genes capable of rectifying or substituting defective genetic material in patients. For instance, in January 2024, according to the American Society of Gene & Cell Therapy, a US-based organization, in fourth quarter of 2024, the number of pre-registration gene therapy programs experienced its largest increase in over a year, rising 83% compared to third quarter of 2024. Consequently, the expanding demand for gene therapies is fueling the expansion of the deoxyribonucleic acid (DNA) manufacturing market.

Which Segment Areas Are Covered In The Deoxyribonucleic Acid (DNA) Manufacturing Market Analysis?

The deoxyribonucleic acid (dna) manufacturing market covered in this report is segmented –

1) By Type: Plasmid Deoxyribonucleic Acid (DNA), Synthetic Deoxyribonucleic Acid (DNA), Gene Synthesis, Oligonucleotide Synthesis

2) By Grade: Good Manufacturing Practices (GMP) Grade, Research And Development Grade

3) By Application: Cell And Gene Therapy, Vaccines, Oligonucleotide-Based Drugs, Other Applications

4) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations

Subsegments:

1) By Plasmid Deoxyribonucleic Acid (DNA): GMP-Grade Plasmid DNA, Non-GMP-Grade Plasmid DNA, High Copy Number Plasmids, Low Copy Number Plasmids, Bacterial Fermentation-Based Plasmid Production, Transfection-Grade Plasmid DNA

2) By Synthetic Deoxyribonucleic Acid (DNA): Enzymatic DNA Synthesis, Chemical DNA Synthesis, Long DNA Fragments, Short DNA Fragments, Single-Stranded Synthetic DNA, Double-Stranded Synthetic DNA

3) By Gene Synthesis: Custom Gene Synthesis, Standard Gene Synthesis, Complex Gene Constructs, Codon Optimization Services, Gene Library Synthesis

4) By Oligonucleotide Synthesis: DNA Oligonucleotides, Modified Oligonucleotides, Long Oligonucleotides, PCR Primers, SiRNA And Antisense Oligos, Adapter And Linker Oligos

What Key Developments And Trends Are Impacting The Deoxyribonucleic Acid (DNA) Manufacturing Market?

Companies prominent in the DNA manufacturing market are concentrating on creating innovative methods, such as GMP-grade plasmid DNA production, to improve the quality, safety, and scalability of gene and cell therapy applications. GMP-grade plasmid DNA production refers to the manufacturing of plasmid DNA under Good Manufacturing Practice (GMP) conditions, which are regulatory guidelines designed to assure the quality, safety, and consistency of biopharmaceutical products. For instance, in April 2025, ProBio Genomics Inc., a US-based contract development and manufacturing organization (CDMO), launched GMP Plasmid DNA Manufacturing Services in Hopewell, complete with in-house analytical testing, method development, and project management. This service offers distinct features, including in-house process development, analytical testing, method development, and project management, thereby removing the necessity for multiple suppliers and accelerating development timelines. The service guarantees a high-quality output with =85% supercoiled plasmid DNA content while diminishing contamination risks. ProBio further provides GMP-like plasmids with a four-week delivery timeline and full GMP-grade plasmids within three months.

Which Global Companies Are Actively Competing In The Deoxyribonucleic Acid (DNA) Manufacturing Market?

Major companies operating in the deoxyribonucleic acid (dna) manufacturing market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Kaneka Corporation, Catalent Inc., Charles River Laboratories International Inc., WuXi Biologics Inc., AGC Biologics Inc., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio USA Inc., Twist Bioscience Corp., Ajinomoto Bio-Pharma Services, OriGene Technologies Inc., DNA Script SAS, Eurofins Genomics LLC, Touchlight Genetics Ltd., Elegen Inc., VGXI Inc., PlasmidFactory GmbH & Co. KG.

Read the full deoxyribonucleic acid (dna) manufacturing market report here:

https://www.thebusinessresearchcompany.com/report/deoxyribonucleic-acid-dna-manufacturing-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Deoxyribonucleic Acid (DNA) Manufacturing Market?

North America was the largest region in the deoxyribonucleic acid (DNA) manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deoxyribonucleic acid (dna) manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Deoxyribonucleic Acid (DNA) Manufacturing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27272&type=smp

Browse Through More Reports Similar to the Global Deoxyribonucleic Acid (DNA) Manufacturing Market 2026, By The Business Research Company

Electronic Equipment Repair Service Market Report 2026

https://www.thebusinessresearchcompany.com/report/electronic-equipment-repair-service-global-market-report

Maintenance Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/maintenance-services-global-market-report

Industrial Maintenance Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/industrial-maintenance-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the deoxyribonucleic acid (dna) manufacturing market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Deoxyribonucleic Acid (DNA) Manufacturing Market expected to grow between 2026 and 2030?

The deoxyribonucleic acid (dna) manufacturing market has experienced rapid expansion in recent years. Forecasts indicate it will expand from $5.58 billion in 2025 to $6.51 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 16.7%. This historical growth stems from factors such as restricted availability of high-quality plasmid and synthetic dna, the dependence on conventional chemical dna synthesis techniques, increasing research and development in cell and gene therapies, a rise in academic and industrial research endeavors, and the escalating need for oligonucleotide-based drugs.

The deoxyribonucleic acid (DNA) manufacturing market is projected to experience substantial expansion in the coming years, with its size expected to reach $11.95 billion by 2030, growing at a compound annual growth rate (CAGR) of 16.4%. This anticipated growth over the forecast period is driven by advancements in enzymatic and chemical DNA synthesis technologies, the broadening scope of gene therapy and vaccine pipelines, and the increasing adoption of GMP-grade DNA production. Other contributing factors include a rising demand for long and complex DNA constructs and the integration of automated DNA manufacturing platforms along with digital workflows. Major trends during this period include a heightened demand for GMP-grade DNA for therapeutic applications, increased production of plasmid and synthetic DNA for vaccines, and the wider utilization of gene synthesis and codon optimization services. Furthermore, the expansion of oligonucleotide synthesis for PCR, siRNA, and antisense applications, coupled with the integration of DNA manufacturing into cell and gene therapy pipelines, will also be significant.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27272&type=smp

Which Drivers Are Influencing Market Acceleration In The Deoxyribonucleic Acid (DNA) Manufacturing Market?

The increasing need for gene therapies is anticipated to drive the expansion of the deoxyribonucleic acid (DNA) manufacturing market moving forward. Gene therapies involve techniques that modify or replace faulty genes to treat or prevent diseases. The escalating demand for gene therapies is fueled by the growing prevalence of genetic disorders such as cystic fibrosis, sickle cell anemia, and specific types of inherited blindness. Deoxyribonucleic acid (DNA) manufacturing is vital for gene therapies, providing the high-quality, custom DNA sequences required to develop and deliver therapeutic genes that can correct or substitute defective genetic material in patients. For instance, in January 2024, the American Society of Gene & Cell Therapy, a US-based organization, reported that in the fourth quarter of 2024, the number of pre-registration gene therapy programs saw its largest increase in over a year, rising 83% compared to the third quarter of 2024. Therefore, the growing demand for gene therapies is propelling the growth of the deoxyribonucleic acid (DNA) manufacturing market.

What Leading Segments Are Studied In The Deoxyribonucleic Acid (DNA) Manufacturing Market?

The deoxyribonucleic acid (dna) manufacturing market covered in this report is segmented –

1) By Type: Plasmid Deoxyribonucleic Acid (DNA), Synthetic Deoxyribonucleic Acid (DNA), Gene Synthesis, Oligonucleotide Synthesis

2) By Grade: Good Manufacturing Practices (GMP) Grade, Research And Development Grade

3) By Application: Cell And Gene Therapy, Vaccines, Oligonucleotide-Based Drugs, Other Applications

4) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations

Subsegments:

1) By Plasmid Deoxyribonucleic Acid (DNA): GMP-Grade Plasmid DNA, Non-GMP-Grade Plasmid DNA, High Copy Number Plasmids, Low Copy Number Plasmids, Bacterial Fermentation-Based Plasmid Production, Transfection-Grade Plasmid DNA

2) By Synthetic Deoxyribonucleic Acid (DNA): Enzymatic DNA Synthesis, Chemical DNA Synthesis, Long DNA Fragments, Short DNA Fragments, Single-Stranded Synthetic DNA, Double-Stranded Synthetic DNA

3) By Gene Synthesis: Custom Gene Synthesis, Standard Gene Synthesis, Complex Gene Constructs, Codon Optimization Services, Gene Library Synthesis

4) By Oligonucleotide Synthesis: DNA Oligonucleotides, Modified Oligonucleotides, Long Oligonucleotides, PCR Primers, SiRNA And Antisense Oligos, Adapter And Linker Oligos

Which Trends Are Shaping Activity Within The Deoxyribonucleic Acid (DNA) Manufacturing Market?

Leading companies in the DNA manufacturing market are increasingly focusing on innovative strategies, such as GMP-grade plasmid DNA production, to enhance the quality, safety, and scalability of gene and cell therapy applications. GMP-grade plasmid DNA production signifies the creation of plasmid DNA under Good Manufacturing Practice (GMP) conditions, which are regulatory guidelines established to ensure the quality, safety, and consistency of biopharmaceutical products. For instance, in April 2025, ProBio Genomics Inc., a US-based contract development and manufacturing organization (CDMO), launched GMP Plasmid DNA Manufacturing Services in Hopewell. This service incorporates in-house analytical testing, method development, and project management. Its distinguishing features include internal process development, analytical testing, method development, and project management, thereby removing the need for multiple suppliers and shortening development timelines. The service guarantees a high-quality output with =85% supercoiled plasmid DNA content while effectively mitigating contamination risks. ProBio additionally provides GMP-like plasmids with a four-week delivery timeline and full GMP-grade plasmids available within three months.

Which Major Firms Are Strengthening Their Position In The Deoxyribonucleic Acid (DNA) Manufacturing Market?

Major companies operating in the deoxyribonucleic acid (dna) manufacturing market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Kaneka Corporation, Catalent Inc., Charles River Laboratories International Inc., WuXi Biologics Inc., AGC Biologics Inc., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio USA Inc., Twist Bioscience Corp., Ajinomoto Bio-Pharma Services, OriGene Technologies Inc., DNA Script SAS, Eurofins Genomics LLC, Touchlight Genetics Ltd., Elegen Inc., VGXI Inc., PlasmidFactory GmbH & Co. KG.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/deoxyribonucleic-acid-dna-manufacturing-global-market-report

Which Region Shows The Strongest Potential For Future Expansion In The Deoxyribonucleic Acid (DNA) Manufacturing Market?

North America was the largest region in the deoxyribonucleic acid (DNA) manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deoxyribonucleic acid (dna) manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Deoxyribonucleic Acid (DNA) Manufacturing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27272&type=smp

Browse Through More Reports Similar to the Global Deoxyribonucleic Acid (DNA) Manufacturing Market 2026, By The Business Research Company

Electronic Equipment Repair Service Market Report 2026

https://www.thebusinessresearchcompany.com/report/electronic-equipment-repair-service-global-market-report

Maintenance Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/maintenance-services-global-market-report

Industrial Maintenance Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/industrial-maintenance-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model